Coronavirus News and Research

RSS

Pfizer and BioNTech COVID-19 vaccine is found to be 90% effective

Pfizer and BioNTech have today announced their new vaccine candidate (BNT162b2) is 90% effective against SARS-CoV-2.

9 Nov 2020

Study may help develop new antiviral drugs against COVID-19

SARS-CoV-2 is a respiratory virus that is responsible for causing COVID-19 infection. It uses multiple steps to attack the body.

9 Nov 2020

Study shows how coronavirus block cells’ ability to produce protective proteins

One of the novel coronavirus' most insidious tricks is that it can block the ability of cells to produce protective proteins without hindering its own ability to replicate.

6 Nov 2020

Highly automated device rapidly detects the presence of COVID-19

Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test.

6 Nov 2020

Researchers use AI tool to study the dynamics behind cancer, Alzheimer’s disease

With the help of artificial intelligence (AI), scientists from the University of Copenhagen have solved a crucial issue that, to date, has been a major barrier to significant protein research into the dynamics behind various diseases, like Parkinson’s, Alzheimer’s, cancer, and also in the development of novel gene-editing techniques and sustainable chemistry.

4 Nov 2020

Researchers use new technology to design promising vaccine for COVID-19

A new nanoparticle vaccine candidate developed for the novel coronavirus creates virus-neutralizing antibodies in mice at levels that are 10 times higher than is observed in individuals, who have recovered from the COVID-19 disease.

4 Nov 2020

Study probes mechanism by which COVID-19 distribution in the body damages erythrocytes

Experts have investigated the mechanisms of COVID-19 inside-the-body distribution related to the damage of erythrocytes.

2 Nov 2020

SARS-Cov-2 spike proteins can directly impact the function of blood-brain barrier

Like a key, SARS-CoV-2 - the virus that causes coronavirus disease 2019 (COVID-19) - attaches to specific molecules on the host cell surface, opening gateways into the cell interior.

30 Oct 2020

Researchers map molecular structure of CV30 antibody to neutralize coronavirus

Scientists at Fred Hutchinson Cancer Research Center in Seattle have shown that a potent antibody from a COVID-19 survivor interferes with a key feature on the surface of the coronavirus's distinctive spikes and induces critical pieces of those spikes to break off in the process.

28 Oct 2020

Proviral and antiviral genes may help develop new therapies for COVID-19

Scientists have screened an unlimited number of cells exposed to the COVID-19 virus and detected genes that appear to close the door on the virus.

27 Oct 2020

Study shows potential avenues of COVID-19 vulnerability in patients with diabetic kidney disease

People with diabetes -- especially the 20 to 40 percent with diabetic kidney disease -- are among the most at risk for serious complications and death from COVID-19.

27 Oct 2020

Researchers identify new potential therapeutic targets for SARS-CoV-2 infection

To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome.

27 Oct 2020

Study: Early travel restrictions have significantly limited the spread of COVID-19 virus

The coronavirus, responsible for the COVID-19 pandemic, has one official name--SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus.

23 Oct 2020

Scientists develop lab-grown lung model to study SARS-CoV-2 infection

A team of Duke University researchers has developed a lab-grown living lung model that mimics the tiny air sacs of the lungs where coronavirus infection and serious lung damage take place. This advance has enabled them to watch the battle between the SARS-CoV-2 coronavirus and lung cells at the finest molecular scale.

23 Oct 2020

Dietary supplement can support immune system to combat SARS-CoV-2 infections

SPIN (SPermidin and eugenol INtegrator for the contrasting incidence of coronavirus in EU population) is a European project powered by EIT Food that is currently developing a dietary supplement supporting the function of the immune system in the fight against SARS-CoV-2 infections in the population at high risk.

22 Oct 2020

New research sheds light on the working principles of advanced biosensing technologies

The COVID-19 pandemic is undoubtedly the most challenging global health burden since the 2nd World War. The pandemic has raised social awareness on the importance of effective and timely diagnosis that may help minimize the risk of contracting and spreading COVID-19.

22 Oct 2020

Scientists use molecular dynamics simulations to reveal the secrets of SARS-CoV-2 virus

The virus wreaking havoc on our lives is an efficient infection machine. Comprised of only 29 proteins (compared to our 400,000), with a genome 1/200,000 the size of ours, SARS-CoV-2 is expertly evolved to trick our cells to contribute its machinery to assist in its propagation.

22 Oct 2020

Coronavirus News and Research

Pfizer and BioNTech COVID-19 vaccine is found to be 90% effective

Study may help develop new antiviral drugs against COVID-19

Study shows how coronavirus block cells’ ability to produce protective proteins

Highly automated device rapidly detects the presence of COVID-19

Researchers use AI tool to study the dynamics behind cancer, Alzheimer’s disease

Researchers use new technology to design promising vaccine for COVID-19

Study probes mechanism by which COVID-19 distribution in the body damages erythrocytes

SARS-Cov-2 spike proteins can directly impact the function of blood-brain barrier

Researchers map molecular structure of CV30 antibody to neutralize coronavirus

Proviral and antiviral genes may help develop new therapies for COVID-19

Study shows potential avenues of COVID-19 vulnerability in patients with diabetic kidney disease

Researchers identify new potential therapeutic targets for SARS-CoV-2 infection

Study: Early travel restrictions have significantly limited the spread of COVID-19 virus

Scientists develop lab-grown lung model to study SARS-CoV-2 infection

Dietary supplement can support immune system to combat SARS-CoV-2 infections

New research sheds light on the working principles of advanced biosensing technologies

Scientists use molecular dynamics simulations to reveal the secrets of SARS-CoV-2 virus

Computational study of the structure and dynamics of glycosylated SARS-CoV-2

Scientists develop novel lab testing procedure for detection of SARS-CoV-2 antibodies

SARS-CoV-2 may induce long-term autoimmune disorder due to self-glycan antibody production

Quorum Bio: Where Synthetic Biology Meets Sustainable Farming

Diagnostic Biochips: Pioneering Brain Research Tools for the Future

Commercializing Innovation in a Life Sciences Ecosystem

Latest in Genomics